Redmile Group’s Hologic HOLX Stock Holding History

Redmile Group’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-20,000	Closed	-$734K	–	74
2017 Q3	$734K	Buy	+20,000	New	+$807K	0.04%	58

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Redmile Group's HOLX Position: Q4 2017 in Review

Redmile Group sold out of Hologic (HOLX) in Q4 2017, closing a stake of 20,000 shares — an estimated $734K sold.

Redmile Group first reported a position in HOLX in Q3 2017 and held it in 1 quarter. The position peaked at $734K in Q3 2017. 472 funds tracked by Wall St. Rank hold HOLX as of Q4 2017.

Redmile Group reported no remaining Hologic position as of Q4 2017 after selling out during the quarter.
Redmile Group sold 20,000 Hologic shares in Q4 2017, an estimated $734K.
Redmile Group first reported a position in Hologic in Q3 2017 and held it in 1 quarter.
Redmile Group's Hologic position peaked at $734K in Q3 2017.
472 funds tracked by Wall St. Rank held Hologic as of Q4 2017.

Based on Redmile Group's 13F filing for Q4 2017, filed 14 Feb 2018.